TSE:MFC

Manulife Financial (MFC.TO)

54.00
+0.50 (0.93%)
as of Jun 5, 2026, 8:00:00 pm Market Open.
1635 watching
0
Investor Insights
star iconJun 6, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) is viewed positively by many experts, who highlight its strong performance in Asia and robust wealth management services. The company is seen as a good long-term investment, particularly due to its attractive dividend yield and relatively low price-to-earnings ratio compared to banks. However, there are concerns regarding short-term earnings fluctuations, particularly in alternative portfolio results and U.S. operations. Market analysts suggest that while the stock has had a good run, cautious investors should watch for strategic entry points, as some believe it may be susceptible to macroeconomic challenges. Overall, the sentiment is that MFC is a solid income stock with potential for growth as it continues to navigate its complex business landscape.

consensus icon
Consensus
Hold
valuation icon
Valuation
Fair Value
review icon
Similar
GWO
COMMENT
You can write calls to lower your risk.
HOLD
Stock has not down well. Just as you think they are heading for a breakout, another issue sideswipes them. Will have to take a write down on their insurance policies in Japan, which was the fastest growing part of their business. Higher interest rates are good for their business and the stock market has improved. Think it has a lot more intrinsic value than the current price. You have to be patient.
TOP PICK
Thinks it could move back up to possibly the $20 level. $16 is the exit price.
DON'T BUY
Not positive on this one. Sold his holdings when he discovered it was really a leverage on the US stock market and US bond market interest rates. Would rather buy a life insurance company for their business, not their exposure to interest rates or the stock market.
PAST TOP PICK
(A Top Pick Apr 1/10. Down 11.26%.) Deploying its capital properly.
PAST TOP PICK
(Top Pick Apr 19/10, Down 10.42%) There is a bit of headwind at $19. Weak today because of a story in the paper today. This stock deserves a higher multiple. In 18-24 months they should be in good enough shape to raise the dividend again.
PAST TOP PICK
(A Top Pick Aug 19/10. Up 20.71%.) Technically it should go higher. Likes the sector.
BUY
Within a year you could see this stock north of $10. Solidified balance sheet, have all the capital they need. They have more credibility here. Delivered better numbers the last two quarters. Good international diversification. It’s the high-risk play in the financials.
BUY
$24 model price. He still recommends it. Add on any dips.
PAST TOP PICK
(Top Pick Mar 16/10, Down 13.90%) Still likes it. Thinks as interest rates and bond yields go up, they will make much more from assets under management. Doesn’t think their interests in Japan are material to their results. Investors are unduly negative on the stock.
DON'T BUY
Stock has been struggling for the last little while. Resistance at current levels. Out of the period of seasonal strength. Between Oct and Jan is it’s strong time. Different than banks, which are Feb to May. Stay away for now.
WEAK BUY
Their exposure to Japan shouldn’t be much. In the short term, he prefers banks over life companies.
PAST TOP PICK
(Top Pick Apr. 19/10, Down 7.21%) Well-known story, has recovered somewhat, but pulled back very recently. Unhedged to the market and had a billion and a half of product that they had to guarantee. In 12 to 18 months you might see a dividend increase. They have covered the hedge to more than half of where it was.
DON'T BUY
In the event of a market correction, they might benefit because of all the hedging they have done. To him, a permanent marker against them is their error in writing unhedged insurance premiums.
HOLD
Historically they have taken too much risk and not hedged enough on their balance sheet. If you have a 2-year horizon, this is a good entry point.
Showing 1,321 to 1,335 of 2,279 entries